Posted by john on June 28th, 2006 — in Fioricet News
Surgeons are now using a special plate for back surgeries; rather than putting in metal rods to fuse the backbones together, doctors insert a plate that actually dissolves
Surgeons are now using a special plate for back surgeries.
Rather than putting in metal rods to fuse the backbones together, doctors insert a plate that actually dissolves.
Dissolvable […]
No Comments »
Posted by john on June 26th, 2006 — in Fioricet News
Endo Pharmaceuticals Inc. said today that the Food and Drug Administration granted it final approval for its Opana ER and Opana pain relief drugs.
Opana ER is the extended-release version and Opana is the immediate-release formulation of oxymorphone hydrochloride, an opioid analgesic. Each drug comes in tablet form.
• Endo said it expects to begin U.S. sales […]
No Comments »
Posted by john on June 20th, 2006 — in Fioricet News
TULSA - New treatment for back pain may help thousands of patients avoid surgery.
Spinal disc decompression therapy is a new alternative for treating a herniated disc in the spine.
Until now, the main options for treatment were surgeries that could involve cutting away bone and placing rods, and rising doses of painkilling medicines that often lead […]
No Comments »
Posted by john on June 11th, 2006 — in Fioricet News
June 8 - Millions of people suffer from osteoarthritis. Some dietary supplements promise to ease the pain, but some brands are better than others.
Water exercise can be effective at soothing the debilitating pain of arthritis. Besides trying gentle exercise, arthritis sufferers spend millions on a variety of dietary supplements.
Consumer Reports’ Chief Medical Advisor, Dr. Marvin […]
No Comments »
Posted by john on June 2nd, 2006 — in Fioricet News
DOW JONES NEWSWIRES
Labopharm Inc. (DDSS) has granted GlaxoSmithKline (GSK) exclusive rights to distribute its once-daily tramadol product in Mexico.
The Laval, Que. pharmaceutical company said the agreement expands the existing licensing and distribution arrangement between it and Glaxo, entered into in September 2005, for 20 Latin American and Caribbean countries.
Labopharm said it will supply Glaxo with […]
No Comments »